Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 2,176,000 | 1,877,000 | 1,759,000 | 1,978,000 | 4,234,000 |
Marketable Securities | 20,288,000 | 17,391,000 | 15,503,000 | 23,991,000 | 48,239,000 |
Receivables | 14,302,000 | 14,012,000 | 13,611,000 | 14,645,000 | 10,552,000 |
Inventories | 8,771,000 | 9,511,000 | 10,132,000 | 12,403,000 | 5,058,000 |
Income taxes - deferred | 7,284,000 | 7,113,000 | 7,502,000 | N/A | N/A |
Other current assets | 1,268,000 | 1,197,000 | 1,409,000 | 1,691,000 | 1,022,000 |
TOTAL | $54,089,000 | $51,101,000 | $49,916,000 | $61,670,000 | $73,784,000 |
Non-Current Assets | |||||
PPE Net | 19,450,000 | 20,041,000 | 21,651,000 | 22,780,000 | 13,173,000 |
Investments And Advances | 10,344,000 | 10,524,000 | 12,081,000 | 13,122,000 | 12,166,000 |
Intangibles | 102,414,000 | 105,373,000 | 107,128,000 | 110,391,000 | 37,921,000 |
Other Non-Current Assets | 5,118,000 | 4,032,000 | 4,337,000 | 4,986,000 | 4,250,000 |
TOTAL | $137,326,000 | $139,970,000 | $145,197,000 | $151,279,000 | $67,510,000 |
Total Assets | $191,415,000 | $191,071,000 | $195,113,000 | $212,949,000 | $141,294,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 5,158,000 | 5,509,000 | 7,769,000 | 5,469,000 | 6,954,000 |
Accounts payable and accrued liabilities | 3,206,000 | 3,078,000 | 3,028,000 | 4,370,000 | 2,481,000 |
Accrued Expenses | 1,853,000 | 1,789,000 | 2,060,000 | 2,242,000 | 1,678,000 |
Other current liabilities | N/A | 12,128,000 | 12,301,000 | 13,583,000 | 10,577,000 |
TOTAL | $24,172,000 | $24,681,000 | $25,924,000 | $37,225,000 | $23,992,000 |
Non-Current Liabilities | |||||
Long Term Debt | 39,010,000 | 37,765,000 | 38,281,000 | 43,193,000 | 32,402,000 |
Other Non-Current Liabilities | 23,220,000 | 24,393,000 | 23,357,000 | 24,247,000 | 16,228,000 |
TOTAL | $79,175,000 | $79,512,000 | $79,107,000 | $85,278,000 | $51,052,000 |
Total Liabilities | $103,347,000 | $104,193,000 | $105,031,000 | $122,503,000 | $75,044,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 8,009,951 | 8,038,278 | 8,066,134 | 8,070,373 | 8,069,536 |
Common Shares | 443,000 | 443,000 | 443,000 | 443,000 | 443,000 |
Retained earnings | 42,873,000 | 42,010,000 | 42,429,000 | 40,426,000 | 54,835,000 |
Other shareholders' equity | -3,219,000 | -3,937,000 | -1,549,000 | 712,000 | -2,037,000 |
TOTAL | $88,068,000 | $86,878,000 | $90,082,000 | $90,446,000 | $66,250,000 |
Total Liabilities And Equity | $191,415,000 | $191,071,000 | $195,113,000 | $212,949,000 | $141,294,000 |